Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.
about
Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma: what is the evidence?Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial.Reviewing cancer care team effectiveness.Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial.Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data.Evaluation of the impact of a flowchart-type leaflet for cancer inpatients.The use of capecitabine in daily practice: a study on adherence and patients' experiencesAdherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice.A Systematic Review of Adherence to Oral Antineoplastic TherapiesInterventions to promote adherence with oral agents.Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study.Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature.Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.Adherence to oral antineoplastic agents by cancer patients: definition and literature review.Adherence and patients' experiences with the use of oral anticancer agents.Improving adherence to oral cancer therapy in clinical practice.Medication adherence to oral cancer therapy: The promising role of the pharmacist.Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer.Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?Medication adherence: A practical measurement selection guide using case studies.Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy.Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab.Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center
P2860
Q34757945-0BA3D874-7125-4F21-902A-8B7018DE62A3Q34974434-0F61D01B-81FE-4FDF-B32C-E1254B627919Q35625669-535E645E-E05D-440B-AD5E-2C051ED15A40Q35682644-55DC7270-559F-4373-8972-AB0805E0F80FQ35917917-5914A545-833A-467D-BF9E-6B9D857D417CQ36030885-6AE3D0AC-22FE-443D-BCDB-B1CAC16149D2Q36165917-002FDA72-0D59-4165-A9C4-5D63D5FDB94CQ36358178-047B3260-5A34-498F-9429-E4996B3F376AQ36650721-BC65F1E5-4D64-4CBF-B7B7-19A1D2E5894BQ36673490-9C35F6F7-A75D-462F-A51B-43B002DE20EFQ36841396-A640C94C-D777-4B93-9B41-967ECB0C0ED0Q37029891-4242361E-D36C-48EB-AB3E-D3C664871979Q37270640-13945465-EFAE-4230-ACC7-E6C45FAC9ED1Q37273881-E8D9EFD1-B975-44F2-B645-5FD41619AE32Q37965653-865376AF-A704-4DB4-8C93-795E2172C88BQ38147533-866A7232-E4E8-49A4-986A-BD5724AEB3FFQ38165220-55C30C39-912F-4F9E-A477-6B486D80353DQ38216035-E24D9357-4C53-4E05-BB2B-C58974A2368DQ38266160-D00F9B91-2687-482E-A82F-52C99E4D722BQ38637908-DEFF4BD6-94DC-44BD-BDD8-17906E09FAD7Q38783329-E92F08C2-0874-4A46-AD2C-380F609F916CQ38887454-46F43D41-3BB4-4A11-9ACF-A52914C2EDB2Q38954197-EDA5977C-A004-484E-AA65-FCAB64A0C3B0Q39666516-1E2336FA-32DE-4A57-AF88-D62CD40A7AB9Q42138629-DEB723C9-1F02-4512-BB81-16A0145B38A7Q51746862-D5F015B5-271A-4B16-9DB7-6A9EC3CFAC8EQ55311510-62FD50EB-B418-44EB-8937-2C2DCC780DF0Q57071452-91332426-F70B-4776-B757-11339D868A2C
P2860
Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@ast
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@en
type
label
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@ast
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@en
prefLabel
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@ast
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@en
P2093
P2860
P1476
Enhancing adherence to capecit ...... ciplinary pharmaceutical care.
@en
P2093
Ingo Schmidt-Wolf
Michael Braun
Peter F Schwindt
Susanne Ringsdorf
Sven Simons
Ulrich J Mey
Ulrich Jaehde
Walther Kuhn
P2860
P2888
P304
P356
10.1007/S00520-010-0927-5
P577
2010-06-16T00:00:00Z